May 2026

39 Articles

Clinical Insights

It’s time to improve antithrombotic therapy! A global perspective for antithrombotic stewardship

18 March 2026
Author(s): W Ageno, L Bertoletti, E Lindhoff-Last, GYH Lip, K Meijer, M Monreal, H Tran, Y Bessada, D Triller, A Burnett, J Ansell

Antithrombotic stewardship (ATS) is a practical, evidence-based care model slowly gaining traction across the globe [1,2]. The impetus for this trend is the persistent evidence for low-quality... more

Intrinsic capacity in older adults: A concise guide for non-geriatricians

16 March 2026
Author(s): Anna Ronca, Viviana Morgese, Philipe de Souto Barreto, Marco Proietti

Over the past decades, there has been a radical and profound change in the population structure, characterised by a gradual increase in the prevalence of individuals in older age groups and a... more

Commentary

Lungs and heart in COPD exacerbations: it takes two to tango

28 March 2026
Author(s): Bartolome R Celli

The lungs and the heart are inseparably linked anatomically, physiologically, and functionally in their shared task of delivering oxygen to the body and removing the carbon dioxide generated by... more

Left atrial appendage closure for atrial fibrillation stroke prevention in hereditary hemorrhagic telangiectasia is effective and safe with simplified, time-limited antithrombotic therapy

21 March 2026
Author(s): Hanny Al-Samkari

In this issue of the European Journal of Internal Medicine, Torres-Iglesias and colleagues present an observational study of 23 patients with hereditary hemorrhagic telangiectasia (HHT) and atrial... more

The critical role of dietary adherence in secondary cardiovascular prevention: Beyond the nutrient composition

12 March 2026
Author(s): Giovanna Muscogiuri, Annamaria Colao

The management of patients with established coronary heart disease (CHD) has traditionally focused on pharmacological interventions and revascularization procedures. However, lifestyle modifications... more

Can heart failure be detected before it occurs? Insights from circulating microRNAs

5 March 2026
Author(s): Andreea Eunice Cosa, Marta Tajes, Josep Comín-Colet

Heart failure (HF) remains one of the most complex and heterogeneous syndromes in healthcare systems, where multiple biological processes converge long before the onset of symptoms. Despite... more

Ideas and Opinions

Hospitalist co-management in multimorbid medical and surgical patients: Insights from the United States and Europe

14 March 2026
Author(s): Ombretta Para, Flora Kisuule, Arántzazu Álvarez-de Arcaya, Antonio Gonzalez Fernandez, Francisco J Rodríguez Gómez, Annette Kurrle, Maximo Bernabeu-Wittel

None.

Internal Medicine Flashcard

Tongue atrophy following unexplained nausea, vomiting, and hiccups

26 January 2026
Author(s): Nobuyuki Ishii, Yuma Sato, Miyuki Miyamoto

A 45-year-old woman was admitted with aspiration pneumonia. She was found to have progressive dysphagia and severe dysarthria. Neurological examination showed a hypernasal voice, diminished gag... more

“Normally distended” bladder in an anuric hemodialysis patient

26 January 2026
Author(s): Koji Muro, Noriko Takahara, Haruyoshi Yoshida

A 72-year-old man with end-stage kidney disease had been on maintenance hemodialysis for 18 years and was completely anuric. He presented with a two-week history of persistent low-grade fever (37 °C... more

Letter to the Editor

Right ventricular-pulmonary circulation uncoupling in older patients with acute HFpEF: is TAPSE/PASP ratio a dichotomous or continuous prognostic marker?

19 March 2026
Author(s): Giuseppe De Matteis, Maria Livia Burzo, Amato Serra, Giovanni Gambassi, Marcello Covino

We appreciated Pagnoni et al insightful comments [1] on our study as they raise important physiopathological and clinical questions that might further increase our understanding of right ventricular-... more

Beyond acute severity: Age as a determinant of in-hospital mortality in acute respiratory failure requiring non-invasive respiratory support in an intermediate care unit

8 March 2026
Author(s): Giulia Sartori, Lorenzo Calabria, Ernesto Crisafulli

The increasing burden of acute illness, together with the progressive reduction in hospital bed capacity across Europe, has intensified the need for optimized management strategies for high-acuity... more

Optimizing cardiorenal protection in HFrEF: from pharmacological mechanisms to clinical implementation. Author's reply

6 March 2026
Author(s): Elisa Russo, Emilio Venturelli, Giovanna Leoncini, Francesca Viazzi, Roberto Pontremoli

We thank Dr. Yuan and coll. [1] for their interest in our review, Renal protection in heart failure with reduced ejection fraction: not all that glitters is gold [2], and for their comments on the... more

Refining the impact of epicardial adipose tissue assessment

3 March 2026
Author(s): Fabio Angeli, Giuseppe Calcaterra, Gianluca Iacobellis, Paolo Verdecchia

We read with great interest the correspondence by Momot et al. [1], which offers a thoughtful and constructive commentary on our recent narrative review exploring the role of epicardial fat... more

Residual respiratory events and daytime sleepiness despite management of obstructive sleep apnoea with and without additional central apnoeas. A three-month follow-up study. Authors’ reply

2 March 2026
Author(s): Michele Vitacca, Mara Paneroni, Nicolino Ambrosino

We thank Fan Yuan, and coll [1] and Linru Zhong and coll [2] for their interest in our study [3]. They add pertinent reflections and critical analysis of our study. We are aware of the unavoidable... more

Microvascular angina: it’s time to move beyond fixed paradigms

2 March 2026
Author(s): Stefano De Servi, Antonio Landi, Bernardo Cortese

Dear Editor,

Management of ANOCA and suspected microvascular angina: integration of plaque-directed and functional strategies

26 January 2026
Author(s): Lukasz Szarpak, Zbigniew Siudak, Andrea Denegri

We read with interest the Ideas and Opinions article by De Servi and colleagues, who question the current emphasis on invasive coronary function testing (CFT) in patients with angina with no... more

Reconsidering residual sleepiness and respiratory events in treated obstructive sleep apnea

23 January 2026
Author(s): Fan Yuan, Letian Qiao, Yuan Liu

We read with great interest the article by Vitacca and colleagues regarding the persistence of respiratory events and daytime sleepiness in patients treated for obstructive sleep apnea [1]. The study... more

TAPSE/PASP ratio in older HFpEF patients: Prognostic insights and geriatric challenges

21 January 2026
Author(s): Gianluca Pagnoni, Aurora Vicenzi, Francesca Coppi

We read with interest the article by De Matteis et al. on the prognostic role of the TAPSE/PASP ratio in older patients with HFpEF hospitalized for acute heart failure [1]. The authors show that RV-... more

Epicardial adipose tissue assessment for earlier cardiovascular risk prediction: from association to clinical utility

18 January 2026
Author(s): Karol Momot, Michal Pruc, Bartosz Maj, Lukasz Szarpak

Calcaterra and colleagues provide a timely narrative review on epicardial adipose tissue (EAT) as an imaging marker of cardiometabolic risk and a potentially modifiable therapeutic target [1]. Yet... more

Optimizing cardiorenal protection in HFrEF: From pharmacological mechanisms to clinical implementation

11 January 2026
Author(s): Miao Yuan

We read with great interest the review article by Russo et al. titled [1]. The authors provided a comprehensive and timely overview of the "four pillars" of heart failure therapy—RAAS inhibitors,... more

SGLT2 Inhibitors in musculoskeletal and connective tissue diseases: Is there a role?

28 December 2025
Author(s): Margarida Lucas Rocha, Vítor Silvestre-Teixeira

Dear Editor,

Heart failure with preserved ejection fraction in the elderly: Clinical, imaging, and biomarker profiles according to global longitudinal strain by cardiac magnetic resonance

15 December 2025
Author(s): Pau Llàcer, Marina García Melero, María Ángeles Fernández, Pedro Torres, Luis Manzano

Dear editor,

Beyond ejection fraction: Small left ventricular volumes define a high-risk phenotype in acute heart failure with preserved ejection fraction

10 December 2025
Author(s): Gema Miñana, Ernesto Valero, Hector Merenciano, Vicent Bodí, Julio Núñez

In patients with heart failure and reduced ejection fraction (HFrEF), larger indexed left ventricular volumes (iLVEDV) have been traditionally considered a surrogate of lower left ventricular... more

Communicating robustness and sex-specific benefit of SGLT2 inhibitors in HFpEF and HFmrEF

9 December 2025
Author(s): Qiang Li, Haixu Hao, Xiaoxuan Yue, Meng An, Yun Yue

Dear Editor,

Integrating sTREM2 into non-invasive pathways for early MASH in MASLD

8 December 2025
Author(s): Wenqi Lv, Xiaoyan Yan

We read with great interest the article by Mahmoudian et al., who evaluated soluble triggering receptor expressed on myeloid cells 2 (sTREM2) as a non-invasive biomarker for early metabolic... more

Original Article

Guideline-directed medical therapy and mortality in heart failure patients hospitalized for COPD exacerbation

14 March 2026
Author(s): Delphine Vauterin, Frauke Van Vaerenbergh, Maxim Grymonprez, Nathaniel M. Hawkins, Leonardo M. Fabbri, Lies Lahousse

Heart failure (HF) is highly prevalent (≥ 15-20%) among patients with chronic obstructive pulmonary disease (COPD) and associated with increased mortality [1,2]. In addition, approximately 20% of HF... more

From hospital to home: Practical guidance when caring for patients with COPD and heart disease

8 March 2026
Author(s): Claus F Vogelmeier, Michael Böhm, John R Hurst, Kathrin Kahnert, Tobias J Lange, Christian Taube, Frederik Trinkmann, Henrik Watz, Klaus F Rabe, Daiana Stolz, Michael Gediga, Leonardo M Fabbri

Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from other chronic conditions, with cardiovascular disease being especially common. The presence of cardiovascular disease... more

Efficacy and harms of polypills for cardiovascular disease prevention: A systematic review and meta-analysis of randomized controlled trials

19 February 2026
Author(s): Brian M. Portela, Ryan M. Shan, Lahar Miriyapalli, Vinay Pasupuleti, Carlos Diaz-Arocutipa, Adrian V. Hernandez

To systematically evaluate polypill effects on cardiovascular (CV) risk factors, CV outcomes, and adverse events in CV disease (CVD) prevention populations.

Direct oral anticoagulants versus Vitamin K antagonist in kidney transplant recipients with atrial fibrillation: A study from a global federated research network

7 February 2026
Author(s): Michele Rossi, Enrico Tartaglia, Amir Askarinejad, Andrea Galeazzo Rigutini, Muath Alobaida, Anirudh Rao, Louise Oni, Claudio Ferri, Tommaso Bucci, Gregory Y.H. Lip

The risk-benefit profile of direct oral anticoagulants (DOACs) in kidney transplant recipients (KTRs) with atrial fibrillation (AF) remains under-investigated.

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis

4 February 2026
Author(s): Valentin Maisons, Antoine Hankard, Alojzija Hočevar, Evangeline Pillebout, Jean-Michel Halimi, Bénédicte Sautenet, Christelle Barbet, Noémie Jourde-Chiche, Alexandre Karras, Jean-François Augusto, Xavier Puéchal, Stanislas Faguer, Christian Lavigne, Kim Baud, Alexis Archambeaud, Hubert de Boysson, Achille Aouba, François Maillot, Benjamin Terrier, Yann Nguyen, Alexandra Audemard-Verger

IgA vasculitis (IgAV) is a systemic vasculitis of the small vessels characterized by immune complexes including immunoglobulin A1 (IgA1) [1]. The clinical picture is a vascular purpura with or... more

Incidence of major adverse cardiovascular events decreases with greater adherence to both Mediterranean and low-fat dietary patterns in secondary prevention patients: a randomized controlled trial

27 January 2026
Author(s): Javier Delgado-Lista, Juan F Alcala-Diaz, Jose D Torres-Peña, Gracia M Quintana-Navarro, Antonio P Arenas Larriva, Francisco Fuentes, Antonio Garcia-Rios, Elena M Yubero-Serrano, Oriol A Rangel-Zuñiga, Antonio Camargo, Fernando Rodriguez-Cantalejo, Niki Katsiki, Pablo Perez-Martinez, Jose Lopez-Miranda, CORDIOPREV Investigators

Diet plays a crucial role in lifestyle interventions for secondary cardiovascular prevention [1–5]. Recent guidelines for reducing cardiovascular risk in secondary prevention populations recommend,... more

Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE

26 January 2026
Author(s): David de Gonzalo-Calvo, María C. García-Hidalgo, Shambhabi Chatterjee, Sabrina Thum, João Pedro Ferreira, Patrick Rossignol, Nicolas Girerd, Job AJ Verdonschot, Stephane Heymans, Jan A Staessen, John GF Cleland, Faiez Zannad, Thomas Thum, Christian Bär

Identifying early pathobiological mechanisms associated with the onset and progression of heart failure (HF) could guide development of preventive strategies.

Left atrial appendage closure in patients with hereditary hemorrhagic telangiectasia and atrial fibrillation: a prospective study and systematic review

6 January 2026
Author(s): R Torres-Iglesias, L Teruel, MA Sánchez-Corral, P Cerdà, B Villanueva, E Gamundí, P Peláez, S Moreno-Lopes, A Iriarte, E Alba, A Portillo, J Gómez-Lara, J Ribas, A Riera-Mestre

Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular disease with a high risk of iron deficiency anemia secondary to epistaxis and gastrointestinal bleeding. Atrial... more

Review Article

Discontinuation of incretin-based therapies in obesity: the complexity of a breakup

13 March 2026
Author(s): Angelo Avogaro, Gian Paolo Fadini

Incretin-based therapies, including mono-, dual-, and emerging triple-agonists, have transformed the pharmacological management of obesity by inducing substantial and sustained weight loss together... more

Pitfalls of autoimmune serological markers and practical diagnostic workflows in connective tissue diseases and rheumatoid arthritis

18 February 2026
Author(s): Chiara Bellocchi, Lorenzo Beretta, Nicola Montano

Laboratory markers represent a highly valuable tool to support the diagnosis of systemic autoimmune diseases. However, their correct interpretation is essential to avoid misdiagnoses, with particular... more

Chronic obstructive pulmonary disease (COPD) and cardiovascular comorbidities: Shedding light on key interactions and therapeutic approaches

6 February 2026
Author(s): Giulia M. Stella, Francesco R. Bertuccio, Valentina Conio, Chandra Bortolotto, Ilaria Salzillo, Edoardo Destefanis Gallo, Vito D’Agnano, Fabio Perrotta, Alice Maccarini, Angelo G. Corsico, Simone Savastano, Antonio Bozzani

Chronic obstructive pulmonary disease (COPD) is often associated with cardiovascular disease and the both conditions share common risk factors (smoke), associated pathophysiological mechanisms (... more

Detecting dementia symptoms in internal medicine settings: clinical red flags, frailty and intervention perspectives

7 January 2026
Author(s): Cira Fundarò, Marina Maffoni

This paper provides a comprehensive overview of dementia in internal medicine hospital settings, highlighting its clinical detection, key red flags and frailty factors, as well as intervention... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.